Catalyst Pharmaceuticals Inc (CPRX) Stock Overview
NASDAQ · Healthcare · Biotechnology
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Catalyst Pharmaceuticals Inc
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States. It offers Firdapse for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); Fycompa,…
Source: Yahoo Finance
Sector & Industry
Catalyst Pharmaceuticals Inc operates in the Healthcare sector, within the Biotechnology industry group. It is listed on the NASDAQ exchange.
Catalyst Pharmaceuticals Inc at a Glance
| Company | Catalyst Pharmaceuticals Inc |
| Ticker | CPRX |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $31.49 |
| Market cap | $3.85B |
| P/E ratio (trailing) | 18.20 |
| EPS (trailing) | $1.73 |
| 52-week high | $32.56 |
| 52-week low | $19.05 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 0.74 |
| Return on equity (ROE) | 24.50% |
| Debt-to-equity | 0.27% |
| Average volume | 2.55M |
| Shares outstanding | 122.42M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 182 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Frequently Asked Questions
- What is Catalyst Pharmaceuticals Inc's current P/E ratio?
- Catalyst Pharmaceuticals Inc (CPRX) has a trailing P/E ratio of 18.20 as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Catalyst Pharmaceuticals Inc's market capitalisation?
- Catalyst Pharmaceuticals Inc's market cap is $3.85B based on our latest snapshot. See how it ranks by market cap →
- What is CPRX's 52-week range?
- Over the past 52 weeks, CPRX has traded between $19.05 and $32.56. What does the 52-week range mean? →
- How volatile is Catalyst Pharmaceuticals Inc compared to the market?
- Catalyst Pharmaceuticals Inc has a beta of 0.74, meaning it has historically moved less than the broader market. What does beta measure? →
- Does Catalyst Pharmaceuticals Inc pay a dividend?
- Catalyst Pharmaceuticals Inc does not currently pay a dividend according to our latest data.
- What exchange is CPRX listed on?
- CPRX is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is Catalyst Pharmaceuticals Inc in?
- Catalyst Pharmaceuticals Inc is classified in the Healthcare sector. Compare with Healthcare peers →
Prefer raw numbers at a glance? Browse our size and reference charts for quick lookups.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Philip Fisher on what makes a business worth owning for the long term.
Check Price →